MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    SAA Positivity Rate Amongst Dual LRRK2-GBA1, GBA1 and LRRK2 Carriers with Parkinson’s Disease

    P. Ponger, A. Nair, N. Johnson, C. Caspell-Garcia, D. Lafontant, R. Alcalay, P. Ppmi (Heidelberg, Australia)

    Objective: We investigated positivity rate in dual GBA1+LRRK2-PD by comparing GBA1+LRRK2-PD carriers(n=13), GBA1-PD(n=169) and LRRK2-PD(n=175). Background: GBA1 and LRRK2 variants represent the most common genetic…
  • 2026 International Congress

    Can people with Parkinson’s disease improve gait adaptation skills via upregulation of the posterior parietal cortex?

    T. Ogawa, C. Guedes, C. Mvomo, L. Hajjaji, J. Bedime, A. Potvin-Desrochers, C. Paquette (Montreal, Canada)

    Objective: To examine whether the upregulation of the posterior parietal cortex (PPC) facilitates gait adaptation on the split-belt treadmill (SBT) and its transfer to overground…
  • 2026 International Congress

    Parkinson’s Disease and Osteoporosis Comorbidity: A Bibliometric Analysis and Exploration of Mechanistic Pathways and Key Genes

    L. Xiao, J. Fan, Y. Wu, K. Liao, L. Zhuang (Guangzhou, China)

    Objective: Explore the association between Parkinson’s disease (PD) and osteoporosis (OP). Background: In recent years, PD and OP have emerged as significant global public health burdens[1,…
  • 2026 International Congress

    Hot and Fast but Still Parkinson’s Disease: A Case of Dyskinesia-Hyperpyrexia Syndrome

    T. Coradine, P. Fraiman, D. Salarini, C. Pereira, K. Couto, G. Chung, M. Soares (São Paulo, Brazil)

    Objective: To describe a case of dyskinesia-hyperpyrexia syndrome (DHS), a rare medical emergency associated with Parkinson’s disease. Background: DHS is a rare but potentially life-threatening…
  • 2026 International Congress

    Natural History of Sialidosis Type I: A Prospective Longitudinal Follow-Up Study of Clinical and Electrophysiological Markers

    BY. Gu, YC. Kuo, HW. Hsueh, SP. Fan, CW. Lin, CY. Chien, TK. Lin, MY. Lan, YY. Chang, NC. Lee, YH. Chien, WL. Hwu, CH. Lin (Taipei, Taiwan)

    Objective: We performed a prospective analysis to determine the natural history as well as changes of electrophysiological markers in a cohort of Sialidosis type I.…
  • 2026 International Congress

    Patient-Defined Disease Progression in Parkinson Disease: Towards Patient-Relevant Outcome Measures

    C. Gonzalez-Robles, A. Schrag, R. Weil, M. Burnell, G. Mills, ML. Zeissler, J. Carpenter, S. Gandhi, C. Carroll, T. Foltynie (London, United Kingdom)

    Objective: To carry out a survey on a representative sample of people with Parkinson’s (PwP) about their lived experience of a comprehensive list of Parkinson…
  • 2026 International Congress

    The Clinical and Biological effects of a Whole Foods and Plant-Based Dietary Intervention in Parkinson’s Disease

    B. Boon, S. Meles, B. Bloem, T. van Laar, E. Postma (Groningen, Netherlands)

    Objective: The Plants for Parkinson trial aims to investigate whether prolonged adherence to a plant-based and whole foods-derived dietary pattern can alleviate motor- and gastrointestinal…
  • 2026 International Congress

    Access to rehabilitation therapy for people with Parkinson’s disease in Rome, Italy

    G. Di Lazzaro, D. Genovese, AT. Cimmino, P. Zinzi, AR. Bentivoglio, P. Calabresi (Rome, Italy)

    Objective: This survey aimed to evaluate patients’ awareness of healthcare roles, access to care, and use of rehabilitation services in the Rome region, Italy. Background:…
  • 2026 International Congress

    A Cerner-based Electronic Prescribing and Medicines Administration (EPMA) Parkinson’s Medicines Care Plan Reduces Time-Critical Medication (TCM) Errors.

    T. Lessware, R. Lal, M. Andrews, D. Trivedi, J. Mathews, E. Bhadra, C. Budu, D. Gallagher, A. Noyce, T. Boyle (London, United Kingdom)

    Objective: To audit inpatient Parkinson's medication management and implement an EPMA care plan to improve reliability of time-critical prescribing. Background: Parkinson’s UK consistently report that…
  • 2026 International Congress

    A Tiered Fecal Biomarker Approach to Identify Gut–Brain Axis Phenotypes in Young-Onset Parkinsonism in a Clinical Setting with Limited Resources

    N. Raisa, F. Aushi (Malang, Indonesia)

    Objective: To explore the feasibility of a tiered fecal biomarker testing approach to identify potential gut–brain axis phenotypes in patients with young-onset parkinsonism in a…
  • « Previous Page
  • 1
  • …
  • 139
  • 140
  • 141
  • 142
  • 143
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley